November 2 Research Roundup: Skinny Mice, Why Weed Affects Women Differently Than Men, and How a Virus Kills Cancer Cells

글 내용 전체보기

Non-Profit Aims to Harness Ecstasy to Treat PTSD

글 내용 전체보기

A Llama Antibody Could Be the Key to a Universal Flu Vaccine

글 내용 전체보기

Early November Brings More Quarterly Reports

글 내용 전체보기

AbbVie Follows Trend of Big Pharma Setting Office-Labs in Biotech Clusters

글 내용 전체보기

Illumina Acquires Pacific Biosciences for $1.2 Billion

글 내용 전체보기

FDA Advisors Overwhelmingly Reject Alkermes Depression Drug

글 내용 전체보기

Epidiolex rollout: $32,500 list price spurs critics as first cannabis drug hits shelves

글 내용 전체보기

FiercePharmaAsia—Genentech espionage case; Astellas’ gene and cell investment; Takeda earnings

글 내용 전체보기

Celgene lines up for $600M Revlimid boost as Rituxan combo scores in lymphoma

글 내용 전체보기

Tale of 2 CEOs: Merck chief treads carefully on pricing, while Pfizer’s Read predicts more hikes

글 내용 전체보기

Shire’s Takhzyro gets off to hot start, boosting immunology sales ahead of Takeda buyout

글 내용 전체보기

Omeicos raises €17M to run phase 2 atrial fibrillation trial

글 내용 전체보기

FDA panel slams Alkermes’ opioid-based depression drug

글 내용 전체보기

Illumina buys PacBio to shore up DNA sequencing dominance

글 내용 전체보기

GSK to ramp-up Shingrix vaccine as demand outstrips supply

글 내용 전체보기

Q3 saw $1.5bn in biotech IPOs, and no slowdown in sight

글 내용 전체보기

Larvae Help in Search for Appetite Suppressants

글 내용 전체보기

Inspiring new drug discovery by pseudo natural products

글 내용 전체보기

Eurofins scientific acquires two North American companies

글 내용 전체보기

Lonza sells water care business to focus on healthcare

글 내용 전체보기